AAPG Ascentage Pharma Group International
$16.10▼ -3.48%
Healthcare
Other
After hours
$16.10▲ +0.00%
Sep 11, 7:30 PM ET
Volume 7.2K
Avg Volume (10D) 7.0K
Key Metrics & Fundamentals
Market Cap
$1.50B
P/E Ratio
–
Div Yield
–%
52W Range
16.03 - 40.48
% vs 50 MA
-11.32%
% vs 200 MA
-28.64%
RSI-14
38.9
MACD Histogram
-0.0700
Beta (1Y vs SPY)
1.32
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 12:00 PM
Ascentage Pharma Group International (SEHK:6855) Could Be 18% Undervalued After Half Year Losses
Simply Wall St. · Aug 28, 2026 5:07 AM
ASCENTAGE PHARMA GROUP INTERNATIONAL Q2 2026 Earnings Call Summary
Moby · Aug 21, 2026 12:30 PM
Ascentage Pharma Group International H1 Earnings Call Highlights
MarketBeat · Aug 20, 2026 3:04 PM
Ascentage Pharma H1 Loss Widens, Revenue Rises
MT Newswires · Aug 20, 2026 7:28 AM
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
GlobeNewswire · Aug 19, 2026 11:00 PM
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
GlobeNewswire · Aug 13, 2026 12:00 PM
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
GlobeNewswire · Aug 5, 2026 1:07 PM
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
GlobeNewswire · Aug 5, 2026 12:00 PM
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
GlobeNewswire · Aug 2, 2026 11:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for AAPG.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.